KRISTOFFER GUERRERO: Open Payments
NPI 1699554568 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,122 in 93 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,241 · 2025 $2,122
Food & beverage: $2,122
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $319 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $273 |
| Alkermes, Inc. | 9 | $209 |
| Lundbeck LLC | 8 | $190 |
| ABBVIE INC. | 9 | $176 |
| Noven Therapeutics, LLC | 8 | $144 |
| Axsome Therapeutics, Inc. | 5 | $121 |
| Vanda Pharmaceuticals Inc. | 5 | $120 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, ARISTADA, Xelstrym, Auvelity, FANAPT.
Industry payments across FL — which companies pay providers there.
